HAL vs PRAX · P/E 9.3, $19.05B cap vs rev $8.6M
Halliburton Company (HAL) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the HAL and PRAX stock pages for the full models.
Not investment advice.